Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer

NCT00214838 is registered in ClinicalTrials.gov with Callisto Pharmaceuticals as lead sponsor.

NCT NCT00214838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer
Lead sponsor
Callisto Pharmaceuticals
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2005
Completion date
March 31, 2007
Enrollment
61
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer